NUVL SCHEDULE 13G/A: SEC filing
Paradigm BioCapital Advisors LP and affiliated reporting persons
Filed with the SEC on · accession 0001104659-26-128305
NUVL filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
Paradigm BioCapital Advisors LP and affiliated reporting persons filed an amended Schedule 13G indicating they no longer beneficially own any shares of Nuvalent, Inc. Class A Common Stock as of September 30, 2026, down from a previously reported position.
Key details
✦ Ask GOAX AI about this filing — what it means for NUVL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NUVL?
Click hereFrequently asked questions
What did NUVL file with the SEC on Nov 16, 2026?
NUVL filed a SCHEDULE 13G/A (SEC filing). Paradigm BioCapital Advisors LP and affiliated reporting persons filed an amended Schedule 13G indicating they no longer beneficially own any shares of Nuvalent, Inc. Class A Common Stock as of September 30, 2026, down from a previously reported position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other NUVL SEC filings
Get alerts when NUVL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days